Advertisement
Original Communications| Volume 131, ISSUE 3, P277-286, March 2002

Download started.

Ok

Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer

      Abstract

      Background. The technique of sentinel lymph node (SLN) biopsy in patients with breast cancer varies among reports, and the optimal method remains to be established, particularly with regard to the site of radiotracer injection. The aim of this study was to compare periareolar and peritumoral injection of radiotracer in detecting SLN in patients with breast cancer. Methods. Patients with T1-2 breast cancer (n = 155) were enrolled in this study. In phase 1 (n = 62), SLN biopsy was performed by using peritumoral injection of blue dye alone followed by backup axillary lymph node dissection. In phase 2, SLN biopsy was performed by using peritumoral injection of blue dye and peritumoral (group A, n = 41) or periareolar (group B, n = 52) injection of technetium 99m tin colloid. Results. In phase 1, the detection rate of SLN was 81% and the false-negative rate was 5.6%, indicating our skill in SLN biopsy. In phase 2, the success rate of lymphoscintigraphy was significantly (P <.001) higher in group B (90%) than in group A (51%). The mean ex vivo radioactivity of SLN in group B (117 counts per second; range, 5 to 900) was also significantly (P <.05) higher than in group A (51 counts per second; range, 8 to 260). In addition, the detection rate of SLN was significantly (P <.05) higher in group B (100%) than in group A (90%). Conclusions. Periareolar injection of radiotracer for SLN biopsy is superior to peritumoral injection because of its simplicity, achieving a high success rate in lymphoscintigraphy and SLN detection. (Surgery 2002;131:277-86.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cabanas RM
        An approach for the treatment of penile carcinoma.
        Cancer. 1977; 39: 456-466
        • Morton DL
        • Wen DR
        • Wong JH
        • Economou JS
        • Cagle LA
        • Storm FK
        • et al.
        Technical details of intraoperative lymphatic mapping for early stage melanoma.
        Arch Surg. 1992; 127: 392-399
        • Giuliano AE
        • Kirgan DM
        • Guenther JM
        • Morton DL
        Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
        Ann Surg. 1994; 220: 391-401
        • Krag DN
        • Weaver DL
        • Alex JC
        • Fairbank JT
        Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.
        Surg Oncol. 1993; 2: 335-340
        • Albertini JJ
        • Lyman GH
        • Cox C
        • Yeatman T
        • Balducci L
        • Ku N
        • et al.
        Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.
        JAMA. 1996; 276: 1818-1822
        • Krag D
        • Weaver D
        • Ashikaga T
        • Moffat F
        • Klimberg VS
        • Shriver C
        • et al.
        The sentinel node in breast cancer: a multicenter validation study.
        N Engl J Med. 1998; 339: 941-946
        • Cox CE
        • Pendas S
        • Cox JM
        • Joseph E
        • Shons AR
        • Yeatman T
        • et al.
        Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
        Ann Surg. 1998; 227: 645-653
        • Veronesi U
        • Paganelli G
        • Galimberti V
        • Viale G
        • Zurrida S
        • Bedoni M
        • et al.
        Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
        Lancet. 1997; 349: 1864-1867
        • Miltenburg DM
        • Miller C
        • Karamlou TB
        • Brunicardi FC
        Meta-analysis of sentinel lymph node biopsy in breast cancer.
        J Surg Res. 1999; 84: 138-142
        • McMasters KM
        • Tuttle TM
        • Carlson DJ
        • Brown CM
        • Noyes RD
        • Glaser RL
        • et al.
        Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.
        J Clin Oncol. 2000; 18: 2560-2566
        • Sandrucci S
        • Casalegno PS
        • Percivale P
        • Mistrangelo M
        • Bombardieri E
        • Bertoglio S.
        Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures.
        Tumori. 1999; 85: 425-434
        • Klimberg VS
        • Rubio IT
        • Henry R
        • Cowan C
        • Colvert M
        • Korourian S.
        Subareolar versus peritumoral injection for location of the sentinel lymph node.
        Ann Surg. 1999; 229: 860-865
        • Mertz L
        • Mathelin C
        • Marin C
        • Gairard B
        • Chenard MP
        • Brettes JP
        • et al.
        Subareolar injection of 99m-Tc sulfur colloid for sentinel nodes identification in multifocal invasive breast cancer [in French].
        Bull Cancer. 1999; 86: 939-945
        • Kern KA
        Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
        J Am Coll Surg. 1999; 189: 539-545
        • Kern KA
        • Rosenberg RJ
        Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid.
        J Am Coll Surg. 2000; 191: 479-489
        • Borgstein PJ
        • Meijer S
        • Pijpers RJ
        • van Diest PJ
        Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method.
        Ann Surg. 2000; 232: 81-89
        • Giuliano AE
        Mapping a pathway for axillary staging: a personal perspective on the current status of sentinel lymph node dissection for breast cancer.
        Arch Surg. 1999; 134: 195-199
        • Giuliano AE
        • Haigh PI
        • Brennan MB
        • Hansen NM
        • Kelley MC
        • Ye W
        • et al.
        Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.
        J Clin Oncol. 2000; 18: 2553-2559
        • Cox CE
        • Bass SS
        • Boulware D
        • Ku NK
        • Berman C
        • Reintgen DS
        Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma.
        Ann Surg Oncol. 1999; 6: 553-561
        • Morton DL
        Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation?.
        Cancer J Sci Am. 1997; 3: 328-330
        • McMasters KM
        • Giuliano AE
        • Ross MI
        • Reintgen DS
        • Hunt KK
        • Byrd DR
        • et al.
        Sentinel-lymph-node biopsy for breast cancer: not yet the standard of care.
        N Engl J Med. 1998; 339: 990-995
        • Grant RN
        • Tabah EJ
        • Adair FE
        The surgical significance of the subareolar lymph plexus in cancer of the breast.
        Surgery. 1953; 33: 71-78
        • Halsell JT
        • Smith JR
        • Bentlage CR
        • Park OK
        • Humphreys Jr, JW
        Lymphatic drainage of the breast demonstrated by vital dye staining and radiography.
        Ann Surg. 1965; 162: 221-226
        • Hill AD
        • Tran KN
        • Akhurst T
        • Yeung H
        • Yeh SD
        • Rosen PP
        • et al.
        Lessons learned from 500 cases of lymphatic mapping for breast cancer.
        Ann Surg. 1999; 229: 528-535
        • Strand SE
        • Persson BR
        Quantitative lymphoscintigraphy I: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits.
        J Nucl Med. 1979; 20: 1038-1046
        • Uren RF
        • Howman-Giles RB
        • Thompson JF
        • Malouf D
        • Ramsey-Stewart G
        • Niesche FW
        • et al.
        Mammary lymphoscintigraphy in breast cancer.
        J Nucl Med. 1995; 36: 1775-1780
        • Gulec SA
        • Moffat FL
        • Carroll RG
        • Krag DN
        Gamma probe guided sentinel node biopsy in breast cancer.
        Q J Nucl Med. 1997; 41: 251-261
        • Paganelli G
        • De Cicco C
        • Cremonesi M
        • Prisco G
        • Calza P
        • Luini A
        • et al.
        Optimized sentinel node scintigraphy in breast cancer.
        Q J Nucl Med. 1998; 42: 49-53
        • Linehan DC
        • Hill AD
        • Akhurst T
        • Yeung H
        • Yeh SD
        • Tran KN
        • et al.
        Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients.
        Ann Surg Oncol. 1999; 6: 450-454
        • Imoto S
        • Murakami K
        • Ikeda H
        • Fukukita H
        • Moriyama N.
        Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer.
        Ann Nucl Med. 1999; 13: 325-329
        • Borgstein PJ
        • Pijpers R
        • Comans EF
        • van Diest PJ
        • Boom RP
        • Meijer S.
        Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
        J Am Coll Surg. 1998; 186: 275-283
        • Doting MH
        • Jansen L
        • Nieweg OE
        • Piers DA
        • Tiebosch AT
        • Koops HS
        • et al.
        Lymphatic mapping with intralesional tracer administration in breast carcinoma patients.
        Cancer. 2000; 88: 2546-2552
        • Veronesi U
        • Paganelli G
        • Viale G
        • Galimberti V
        • Luini A
        • Zurrida S
        • et al.
        Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.
        J Natl Cancer Inst. 1999; 91: 368-373
        • Paganelli G
        • De Cicco C
        • Chinol M.
        Sentinel node localization by lymphoscintigraphy: a reliable technique with widespread applications.
        Recent Results Cancer Res. 2000; 157: 121-129
        • Pijpers R
        • Meijer S
        • Hoekstra OS
        • Collet GJ
        • Comans EF
        • Boom RP
        • et al.
        Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
        J Nucl Med. 1997; 38: 366-368
        • Rahusen FD
        • Pijpers R
        • Van Diest PJ
        • Bleichrodt RP
        • Torrenga H
        • Meijer S.
        The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer.
        Surgery. 2000; 128: 6-12